Spectrum Pharmaceuticals ... (SPPI)
NASDAQ: SPPI
· Real-Time Price · USD
1.02
-0.01 (-0.97%)
At close: Jul 31, 2023, 9:56 PM
Spectrum Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 25.77M | 10.15M | 39K | 39K | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.9M | 1.84M | 45K | 42K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 22.87M | 8.32M | -6K | -3K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -63.51M | -72.7M | -97.91M | -109.4M | -128.08M | -147.7M | -173.74M | -180.21M | -172.63M |
Interest Income | 1.42M | 871K | 298K | 181K | 90K | 163K | 246K | 423K | 722K |
Pretax Income | -67.68M | -78.06M | -106.09M | -117.25M | -138.13M | -158.43M | -168.66M | -184.1M | -166.4M |
Net Income | -65.06M | -75.31M | -106.09M | -117.25M | -138.33M | -158.63M | -158.67M | -174.04M | -155.99M |
Selling & General & Admin | 42.94M | 38.82M | 46.41M | 50.39M | 55.96M | 60.41M | 57.22M | 60.09M | 59.88M |
Research & Development | 43.44M | 42.2M | 51.5M | 59.01M | 72.12M | 87.3M | 116.52M | 120.12M | 112.75M |
Other Expenses | n/a | n/a | n/a | 9K | 9K | 9K | 9K | n/a | n/a |
Operating Expenses | 86.38M | 81.02M | 97.91M | 109.4M | 128.08M | 147.7M | 173.74M | 180.21M | 172.63M |
Interest Expense | 2.09M | 1.16M | 256K | 128K | 11K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 89.23M | 82.81M | 97.91M | 109.4M | 128.08M | 147.7M | 173.74M | 180.21M | 172.63M |
Income Tax Expense | -2.62M | -2.75M | 40K | 24K | 27K | 4K | -66K | -60K | -67K |
Shares Outstanding (Basic) | 201.92M | 183.24M | 188.36M | 175.57M | 169.74M | 154.68M | 159.26M | 155.24M | 145.37M |
Shares Outstanding (Diluted) | 201.92M | 183.24M | 188.36M | 175.57M | 169.74M | 154.68M | 159.26M | 155.24M | 145.37M |
EPS (Basic) | -0.36 | -0.43 | -0.64 | -0.73 | -0.88 | -1.04 | -1.06 | -1.22 | -1.18 |
EPS (Diluted) | -0.36 | -0.43 | -0.64 | -0.73 | -0.88 | -1.04 | -1.06 | -1.22 | -1.18 |
EBITDA | -61.88M | -71.81M | -97.83M | -109.25M | -127.86M | -147.49M | -173.53M | -180.08M | -172.57M |
EBIT | -65.44M | -76.62M | -102.93M | -114.24M | -129.39M | -147.7M | -173.74M | -180.21M | -172.63M |
Depreciation & Amortization | 1.75M | 1.02M | 274K | 295K | 294K | 286K | 578K | 117K | -195K |